Orient EuroPharma , Ltd. Total Assets

Orient EuroPharma , Ltd. posts a total assets of $12B as of June 2026. That compares with $12B in the prior-year period — down 3.8% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Orient EuroPharma , Ltd.'s total assets was $12B. The latest reading is $12B — a 3.8% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Total Assets is one piece of Orient EuroPharma , Ltd.'s financial statement story. At $12B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 4120.TWO's total assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Orient EuroPharma , Ltd.'s other metric pages and overview cover the third.